Pat Soon-Shiong, Chairman of Chan Soon-Shiong Family Foundation, Executive Chairman at ImmunityBio, and Executive Chairman of the Los Angeles Times, shared a post on X:
“Just Arrived in Riyadh as a guest of the nation’s leadership to share clinical breakthroughs that could transform healthcare in the Middle East. The Saudi-USA Biotech Alliance in action. The era of immunotherapy 2.0 has started with the first approval of ANKTIVA + checkpoint.”
Other articles featuring Pat Soon-Shiong on OncoDaily.